Atlas Trials

Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial Hypertension

Clinical trial NCT07356375 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07356375
Sponsor
University of Sao Paulo General Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Pulmonary Arterial Hypertension (PAH)
Start date
2026-03-01
Primary completion
2026-12-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.